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Abstract
Background Transanal minimally invasive surgery
(TAMIS) is emerging as an alternative to transanal endo-
scopic microsurgery. Quality of life (QOL) and functional
outcome are important aspects when valuing a new tech-
nique. The aim of this prospective study was to assess both
functional outcome and QOL after TAMIS.
Methods From 2011 to 2013, patients were prospectively
studied prior to and at least 6 months after TAMIS for
rectal adenomas and low-risk T1 carcinomas using a sin-
gle-site laparoscopy port. Functional outcome was deter-
mined using the Faecal Incontinence Severity Index (FISI).
Quality of life was measured using functional [Faecal
Incontinence Quality of Life (FIQL)] and generic (EuroQol
EQ-5D) questionnaires.
Results The study population consisted of 24 patients 13
men, median age 59 (range 42–83) with 24 tumours [me-
dian distance from the dentate line 8 cm (range 2–17 cm);
median tumour size 6 cm2 (range 0.25–51 cm2); 20 ade-
nomas; 4 low-risk T1 carcinomas]. Post-operative com-
plications occurred in one patient (4 %; grade IIIb
according to Clavien Dindo classification). Compared to
baseline, FISI remained unaffected (9.8 vs 7.3; P = 0.26),
FIQL remained unaffected, and EuroQol EQ-5D improved
(EQ-VAS: 77 vs 83; P = 0.04).
Conclusion There was no detrimental effect of TAMIS
on anorectal function. Overall QOL was improved after
TAMIS, probably due to removal of the tumour, and at
6 months was equal to the general population.
Keywords Transanal minimally invasive surgery 
Anorectal function  Transanal endoscopic microsurgery 
Faecal incontinence  Quality of life
Background
For the local resection of rectal adenomas and selected
rectal carcinomas, transanal endoscopic microsurgery
(TEM), as described by Buess, has emerged as the treat-
ment of choice as it is superior to other local excision
techniques [1–3]. Earlier studies have already shown that
TEM has no impact on anorectal function and improves
quality of life (QOL) [4–7]. Nevertheless, TEM is not
being broadly incorporated into the surgical armamentar-
ium. This may be explained by its high costs and long
learning curve [8, 9].
Since 2010, single-site surgical ports are used as an
alternative to the classical TEM rectoscope in transanal
surgery. To date, many types of single ports have been
explored transanally, such as the single-incision laparo-
scopic surgery port (SILS, Covidien, Mansfield, MA), the
Single Site Laparoscopic Access System (SSL, Ethicon
Endo-Surgery, Cincinnati, OH) and the Gelpoint Path
platform (Applied Medical, Rancho Santa Margarita, CA).
Recently, the acronym TAMIS, meaning transanal mini-
mally invasive surgery, is suggested to avoid commercial
links. TAMIS seems to be embraced by colorectal surgeons
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more than TEM and has already proven to be a feasible and
safe modification [10]. Furthermore, the technique of
TAMIS is advocated to be easier to learn, and because no
specialized insufflator or operating rectoscope is needed, it
is more readily available.
As a next step, efficacy of TAMIS should be balanced
against TEM, including its effect on anorectal function and
QOL. To date, however, impact of TAMIS on the func-
tional outcome and QOL is reported only scarcely and
indirectly [11].
The aim of this prospective study was to analyse the
functional outcome as well as QOL after TAMIS.
Materials and methods
Patients
The study population consisted of patients who were
referred for local excision of a rectal tumour between May
2011 and April 2013. All patients were evaluated preop-
eratively according to a standard protocol including rigid
rectoscopy, tumour biopsy and endorectal ultrasound. Only
rectal adenomas and low-risk T1 carcinomas, i.e. well
differentiated, no signs of lymphangio-invasion and
\3 cm, were considered eligible for this study. Patients
with a pre-existing stoma, patients who underwent con-
version to another technique, patients in whom histology
results post-operative revealed a [T1 carcinoma and
patients who underwent a combined operation were
excluded.
Institutional review board approval was given prior to
the commencement of the study, and in all patients, written
informed consent was obtained.
Surgical procedure
Procedures were performed by two surgeons who are
extensively ([500) experienced in TEM and moderately
(50–100) experienced in TAMIS (P.D. and E.d.G.).
TAMIS was performed using the Single Site Laparoscopic
Access System (SSL, Ethicon Endo-Surgery, Cincinnati,
OH), as previously described [10]. In brief, this procedure
is performed by using a 360 rotatable port in combination
with a 30 laparoscope, providing easy and quick reori-
entation of the instrumentation and easy specimen collec-
tion. A single enema was given 1 h before surgery.
Preoperative antibiotics (cefazoline/metronidazole) were
administered. All patients were operated under general
anaesthesia in the lithotomy position. A pneumorectum of
12–15 mmHg was established using carbon dioxide
insufflation. A full-thickness excision was performed. At
the surgeon’s discretion, the rectal wall defect was closed
using a self-anchoring continuous suture. Operative time
was defined as the time of inserting the SSL retractor until
removal.
Data collection
An independent research coordinator not previously
involved in the patients’ care collected all data. Demo-
graphics, operative details, post-operative length of stay,
post-operative complications and functional outcome were
recorded for each patient.
Before and 6 months after TAMIS, patients were asked
to fill out a questionnaire to assess anorectal function and
QOL. We evaluated functional outcome by means of a
detailed questionnaire based on the Faecal Incontinence
Severity Index (FISI) (range 0–61) [12]. Quality of life was
evaluated using the EuroQol EQ-5D/EQ-VAS scores (both,
range 0–100) and the Faecal Incontinence Quality of Life
(FIQL) score [overall score and four domains (lifestyle
issues, coping–behaviour, depression and self-perception
and embarrassment) (all, range 1–4)]. [13] The EuroQol
EQ-5D/VAS scores were compared with a sex- and age-
matched, community-based sample of healthy persons
without co-morbidity [14]. Data are presented as medians
and ranges. Changes within groups were evaluated using
the nonparametric one-sample Wilcoxon’s signed-rank
test. Comparison of these changes between groups was
conducted using the Mann–Whitney U test. A P value of
B0.05 was considered statistically significant.
Results
Between May 2011 and April 2013, 50 patients were found
eligible for this study. Eighteen patients were excluded; in
14 patients, TAMIS was combined with another surgical
technique and four patients required additional surgery
because of high-risk T1 or more invasive carcinoma.
Of the remaining 32 patients, 24 completed both pre-
operative and post-operative questionnaires (response rate
75 %) and were included for analysis. All patients had a
minimal follow-up of 6 months (range 6–8). Eight patients
did not provide us both the completed preoperative and
post-operative questionnaires despite their informed con-
sent and frequent encouragements. None of the eight non-
responding patients developed an early recurrence. Two
patients experienced post-operative haemorrhage, both
treated conservatively. Hence, the reason for non-re-
sponding is not quite clear.
The group consisted of 13 males and 11 females.
Median age was 59 years (range 42–83). Median distance
from the distal tumour margin to the dentate line was 8 cm
(range 2–17 cm), and median tumour size was 6 cm2
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(range 0.25–51 cm2). Twenty-four tumours were removed:
20 adenomas and 4 low-risk T1 carcinomas. The median
proportion of the rectal circumference covered by the
lesion was 25 % (range 5–50). Median operative time was
32 min (range 13–94). One patient (4 %) experienced a
complication consisting of haemorrhage requiring re-op-
eration (grade IIIb according to Clavien Dindo classifica-
tion). In hospital, mortality rate was zero. Median length of
stay was 1 day (range 1–3 days; Table 1).
The mean FISI score decreased from 9.8 ± 2.3 to
7.3 ± 2.2 (P = 0.26). Fifteen patients were completely
continent after surgery (63 %). Five patients (21 %) had a
minor deterioration in FISI score of 8 (range 5–12).
The five patients who experienced an increase in FISI
score had a significant shorter tumour distance to the
dentate line (4.4 vs 7.4 cm; P = 0.04) and a significantly
larger tumour size (21 vs 9 cm2; P = 0.05). The EQ-VAS
score in these patients was significantly lower (71 vs 86;
P = 0.03). A schematic overview is provided in Fig. 1.
The FIQL scores are shown in Table 2. A significant
improvement in the FIQL subscale ‘‘coping behaviour’’
was seen post-operatively (P = 0.02). In patients in whom
the FISI score deteriorated, the FIQL scores were lower at
6 months after TAMIS in all four dimensions (All
P\ 0.05). The size of the tumour and distance to the anal
verge had no significant effect on these FIQL scores.
The general QOL, as evaluated by EQ-VAS and EQ-5D,
is presented in Table 3. From a patient perspective, the
mean general QOL score (EQ-VAS) improved 6 months
after TAMIS compared to baseline (P = 0.03). From a
social perspective, the mean EQ-5D index score remained
equal. EQ-VAS and EQ-5D scores were lower to those of
the sex- and age-matched general population before sur-
gery (both, P\ 0.01), yet were similar 6 months after
TAMIS.
Discussion
This is the first study focusing not only on anorectal
functioning, but also on QOL following TAMIS, which
makes this study unique. In this study, TAMIS proved to be
a safe technique. Overall, anorectal functioning was not
compromised, although in a small subset of patients FISI
increased, depicting a deterioration in functioning. To the
best of our knowledge, there is only one other paper
describing the impact of TAMIS on anorectal functioning.
In the recent study by Schiphorst et al. [15], preoperative
FISI scores were higher than in the current study (mean 21
vs 10). The only obvious differences between both studies
seem to be median age (median 79 vs 59 years) and median
tumour size (18 vs 6 cm2), and this may attribute to the
difference in preoperative FISI scores. Following TAMIS,
in their study in 88 % of patients, continence improved,
whereas in only two patients, functioning deteriorated at
6-month follow-up. In our study, in 79 % of patients,
anorectal functioning improved, and in five patients, it
decreased. As these numbers are limited, conclusions have
to be mitigated, but in our series, deterioration occurred
mainly in more distal located and larger tumours. To
confirm whether these are the real contributing factors,
further studies have to be awaited.
Regarding QOL, a significant improve in FIQL was
observed in the subscale ‘‘coping behaviour’’. Tumour size
and distance from the dentate line had no effect on these
FIQL scores. We also observed a better general QOL score
(EQ-VAS) after TAMIS (P = 0.03). We can only specu-
late on this improvement. However, besides removal of the
tumour which may have led to incontinence-like
Table 1 Procedure-related characteristics
Median duration of operation in minutes (range) 32 (13–94)
Complications (N) 1/24 (4.2 %)
Re-operation for re-bleeding 1
Median length of hospital stay in days (range) 1 (1–3)
Fig. 1 FISI-scores before and
after transanal minimally
invasive surgery (TAMIS)
Table 2 Faecal Incontinence Quality of Life scores
Preoperative 6 months after SPTS P value
Lifestyle 3.8 (0.6) 3.9 (0.4) 0.15
Coping behaviour 3.0 (0.8) 3.6 (0.5) 0.02
Depression 3.6 (0.8) 3.7 (0.5) 0.27
Embarrassment 3.5 (0.5) 3.7 (0.4) 0.08
Total 3.5 (0.6) 3.7 (0.5) 0.12
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symptoms, it seems reasonable a rejoice phenomenon plays
a role. Finally, social QOL (EQ-5D) improved 6 months
after TAMIS, and at that time point, was comparable to the
general population.
Although our study population is small, it is a very
homogenous group, including only patients with adenoma
or a low-risk T1 carcinoma. Only patients who solely
underwent TAMIS, using only one system, were included.
Hereby, the possible influence of other systems or anal
retractors on functional outcome is eliminated.
How are our results compared to studies following
TEM? In earlier studies, we already showed TEM has no
detrimental effect on anorectal functioning [7]. A recent
study by Allaix showed TEM to be safe even after long-
term follow-up. Our study shows TAMIS can compete with
TEM as it comes to anorectal functioning and QOL [16].
However, long-term results have to be awaited. Also, as
TEM has proven safe with respect to local recurrence rates
in RA and T1 rectal carcinomas, TAMIS should produce
equivalent results on these aspects, before it can be
embraced safely.
In conclusion, TAMIS seems to be a safe procedure
without compromising anorectal functioning and improves
QOL in most patients. Nonetheless, more data, especially
on long-term outcome and long-term functional results,
will be required before concluding it is equal to TEM, the
current gold standard procedure.
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N = 24 N = 24 N = 24
EQ-VAS 77 (12) 83* (14) 84 (7)
EQ-5D 82 (11) 88 (10) 89 (6)
Data are mean scores with standard deviation in parentheses. EQ-
VAS score equates to QOL from a patient perspective, EQ-5D score
equates to QOL from a social perspective. The population group was
sex- and age- matched to the analysed patients and derived from a
community-based sample of healthy individuals without co-morbidity
* P = 0.03 comparison with baseline
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